127 related articles for article (PubMed ID: 38251670)
1. Selection of GalNAc-Conjugated si
You M; Tian M; Song Z; Liu Z; Yang B; Zhang S
Nano Lett; 2024 Jan; 24(4):1096-1105. PubMed ID: 38251670
[TBL] [Abstract][Full Text] [Related]
2. Milk-derived exosomes carrying siRNA-KEAP1 promote diabetic wound healing by improving oxidative stress.
Xiang X; Chen J; Jiang T; Yan C; Kang Y; Zhang M; Xiang K; Guo J; Jiang G; Wang C; XiangXu ; Yang X; Chen Z
Drug Deliv Transl Res; 2023 Sep; 13(9):2286-2296. PubMed ID: 36749479
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y
Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872
[TBL] [Abstract][Full Text] [Related]
4. A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1-Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury.
Li G; Liu H; Feng R; Kang TS; Wang W; Ko CN; Wong CY; Ye M; Ma DL; Wan JB; Leung CH
Redox Biol; 2021 Dec; 48():102129. PubMed ID: 34526248
[TBL] [Abstract][Full Text] [Related]
5. Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.
Pang C; Zheng Z; Shi L; Sheng Y; Wei H; Wang Z; Ji L
Free Radic Biol Med; 2016 Feb; 91():236-46. PubMed ID: 26721592
[TBL] [Abstract][Full Text] [Related]
6. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.
Chiou YS; Huang Q; Ho CT; Wang YJ; Pan MH
Free Radic Biol Med; 2016 May; 94():1-16. PubMed ID: 26878775
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
[TBL] [Abstract][Full Text] [Related]
8. Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model.
Kaseda S; Sannomiya Y; Horizono J; Kuwazuru J; Suico MA; Ogi S; Sasaki R; Sunamoto H; Fukiya H; Nishiyama H; Kamura M; Niinou S; Koyama Y; Nara F; Shuto T; Onuma K; Kai H
Kidney360; 2022 Apr; 3(4):687-699. PubMed ID: 35721612
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-141 protects PC12 cells against hypoxia/reoxygenation-induced injury via regulating Keap1-Nrf2 signaling pathway.
Zhou B; Liu HY; Zhu BL; Yue AX
J Bioenerg Biomembr; 2019 Aug; 51(4):291-300. PubMed ID: 31273531
[TBL] [Abstract][Full Text] [Related]
10. Targeting Keap1 by miR-626 protects retinal pigment epithelium cells from oxidative injury by activating Nrf2 signaling.
Xu XZ; Tang Y; Cheng LB; Yao J; Jiang Q; Li KR; Zhen YF
Free Radic Biol Med; 2019 Nov; 143():387-396. PubMed ID: 31446056
[TBL] [Abstract][Full Text] [Related]
11. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
Panieri E; Saso L
Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
[No Abstract] [Full Text] [Related]
13. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
[TBL] [Abstract][Full Text] [Related]
14. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
[TBL] [Abstract][Full Text] [Related]
15. Cell-Permeable Peptide Targeting the Nrf2-Keap1 Interaction: A Potential Novel Therapy for Global Cerebral Ischemia.
Tu J; Zhang X; Zhu Y; Dai Y; Li N; Yang F; Zhang Q; Brann DW; Wang R
J Neurosci; 2015 Nov; 35(44):14727-39. PubMed ID: 26538645
[TBL] [Abstract][Full Text] [Related]
16. Targeting Nrf2/Keap1 signaling pathway by bioactive natural agents: Possible therapeutic strategy to combat liver disease.
Jayasuriya R; Dhamodharan U; Ali D; Ganesan K; Xu B; Ramkumar KM
Phytomedicine; 2021 Nov; 92():153755. PubMed ID: 34583226
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
Lu MC; Zhang X; Wu F; Tan SJ; Zhao J; You QD; Jiang ZY
J Med Chem; 2019 Jul; 62(14):6796-6813. PubMed ID: 31283229
[TBL] [Abstract][Full Text] [Related]
19. A Point Mutation at C151 of
Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
[TBL] [Abstract][Full Text] [Related]
20. Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors.
Richardson BG; Jain AD; Potteti HR; Lazzara PR; David BP; Tamatam CR; Choma E; Skowron K; Dye K; Siddiqui Z; Wang YT; Krunic A; Reddy SP; Moore TW
J Med Chem; 2018 Sep; 61(17):8029-8047. PubMed ID: 30122040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
